Prediction of response to primary chemotherapy for operable breast cancer
- 1 April 1999
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 35 (4) , 574-579
- https://doi.org/10.1016/s0959-8049(99)00005-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.Journal of Clinical Oncology, 1998
- Clinical and pathological response to primary chemotherapy in operable breast cancerEuropean Journal Of Cancer, 1997
- Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patientsEuropean Journal Of Cancer, 1995
- Primary chemotherapy in surgically resectable breast cancerCA: A Cancer Journal for Clinicians, 1995
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- Mutant p53 protein associated with chemosensitivity in breast cancer specimensThe Lancet, 1994
- Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cmAnnals of Oncology, 1991
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988
- Concepts for systemic treatment of micrometastasesCancer, 1975